Omkar Pharmachem has informed about submission of copy of newspapers, one in vernacular language and one in English, in which advertisement for convening the Board Meeting, to consider, approve and take on record the Unaudited financial results along with Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report for the quarter and half year ended on 30th September, 2019, pursuant to regulation 33 of the of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 has been given.
The above information is a part of company’s filings submitted to BSE.